Fjarde AP Fonden Fourth Swedish National Pension Fund lowered its stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 20.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 368,250 shares of the company's stock after selling 97,500 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in Keurig Dr Pepper were worth $11,828,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently modified their holdings of the stock. AMF Tjanstepension AB purchased a new stake in shares of Keurig Dr Pepper during the third quarter worth approximately $2,557,000. Blue Trust Inc. lifted its holdings in Keurig Dr Pepper by 343.6% in the 3rd quarter. Blue Trust Inc. now owns 3,766 shares of the company's stock valued at $141,000 after purchasing an additional 2,917 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in Keurig Dr Pepper by 14.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 12,739 shares of the company's stock worth $477,000 after purchasing an additional 1,651 shares during the last quarter. International Assets Investment Management LLC boosted its stake in Keurig Dr Pepper by 6,430.6% during the 3rd quarter. International Assets Investment Management LLC now owns 114,351 shares of the company's stock worth $4,286,000 after purchasing an additional 112,600 shares during the last quarter. Finally, Lake Street Advisors Group LLC grew its holdings in shares of Keurig Dr Pepper by 12.8% during the third quarter. Lake Street Advisors Group LLC now owns 8,327 shares of the company's stock worth $314,000 after buying an additional 945 shares in the last quarter. Institutional investors and hedge funds own 93.99% of the company's stock.
Insider Buying and Selling at Keurig Dr Pepper
In other news, major shareholder Bevco B.V. Jab purchased 3,619,600 shares of the stock in a transaction dated Wednesday, January 29th. The stock was acquired at an average cost of $33.34 per share, for a total transaction of $120,677,464.00. Following the completion of the transaction, the insider now directly owns 218,063,479 shares in the company, valued at approximately $7,270,236,389.86. This represents a 1.69 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.00% of the company's stock.
Keurig Dr Pepper Trading Up 0.2 %
Shares of NASDAQ KDP traded up $0.08 during mid-day trading on Monday, reaching $34.12. 15,291,826 shares of the company's stock were exchanged, compared to its average volume of 8,981,652. The company's 50-day moving average is $31.80 and its 200-day moving average is $33.94. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.36 and a current ratio of 0.53. The firm has a market capitalization of $46.28 billion, a price-to-earnings ratio of 20.68, a PEG ratio of 2.42 and a beta of 0.61. Keurig Dr Pepper Inc. has a 52-week low of $28.61 and a 52-week high of $38.28.
Keurig Dr Pepper Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be given a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date is Friday, March 28th. Keurig Dr Pepper's dividend payout ratio is presently 55.76%.
Analyst Ratings Changes
KDP has been the topic of several research reports. UBS Group decreased their price target on shares of Keurig Dr Pepper from $42.00 to $37.00 and set a "buy" rating on the stock in a research note on Thursday, January 16th. Deutsche Bank Aktiengesellschaft raised shares of Keurig Dr Pepper from a "hold" rating to a "buy" rating and raised their target price for the stock from $37.00 to $39.00 in a research note on Thursday, December 12th. TD Cowen dropped their price target on Keurig Dr Pepper from $39.00 to $36.00 and set a "hold" rating for the company in a research report on Wednesday, January 8th. Piper Sandler started coverage on Keurig Dr Pepper in a report on Tuesday, January 7th. They issued a "neutral" rating and a $35.00 price target for the company. Finally, Wells Fargo & Company lowered their price objective on Keurig Dr Pepper from $42.00 to $40.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 7th. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $37.50.
Check Out Our Latest Stock Analysis on KDP
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Further Reading

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.